Skip to main content

Table 2 Characteristics of survivors of working age and independent variables of employment by the results of multiple logistic regression analysis

From: Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary

  All patients (n = 140) Inactive employment status (n = 47) Active employment status (n = 93) Univariate analysis Multiple analysis
p ODDS 95% CI p ODDS 95% CI
Age at survey > = 40 yr. 76 (54%) 15 (32%) 61 (66%) <0.001 4.357 2.038–9.316    
vs. <40 yr. 64 (46%) 32 (68%) 32 (34%)
Age at dg. > = 30 yr. 80 (57%) 16 (34%) 64 (69%) <0.001 4.276 2.028–9.016 0.001 3.556 1.548–8.168
vs. <30 yr. 60 (43%) 31 (66%) 29 (31%)
Elapsed time > =10 yr. 66 (47%) 24 (51%) 42 (45%) 0.436 1.325 0.652–2.689    
vs. <10 yr. 74 (53%) 23 (49%) 51 (55%)
Male 69 (49%) 23 (49%) 46 (49%) 0.953 0.979 0.485–1.975    
vs. female 71 (51%) 24 (51%) 47 (51%)
Residence: village 32 (23%) 12 (26%) 20 (22%) 0.592 1.252 0.507–2.062    
vs. city 108 (77%) 35 (74%) 73 (78%)
Education level:          
elementary 50 (36%) 24 (53%) 26 (28%) 0.014 3.346 1.282–8.734 0.032 3.320 1.112–9.914
vs. college 37 (27%) 14 (30%) 38 (41%)       
elementary     0.568 1.336 0.494–3.609 0.235 1.967 0.644–6.007
vs. high school 52 (37%) 8 (17%) 29 (31%)       
Single 68 (50%) 23 (52%) 45 (49%) 0.714 1.144 0.557–2.347    
vs. live together 68 (50%) 21 (48%) 47 (51%)
Stage 3–4 73 (53%) 24 (52%) 41 (45%) 0.399 1.357 0.668–2762    
vs. 1–2 65 (47%) 22 (48%) 51 (55%)
Bulk 42 (32%) 11 (27%) 31 (34%) 0.409 0.710 0.314–1.605    
vs. without bulk 90 (68%) 30 (73%) 60 (66%)
B symptom 61 (46%) 20 (49%) 41 (44%) 0.691 1.161 0.555–2.433    
vs. no B symptom 71 (54%) 21 (51%) 50 (56%)
ECOG 1–2 22 (17%) 8 (20%) 14 (16%) 0.593 1.299 0.497–3.390    
vs. ECOG 0 108 (83%) 33 (80%) 75 (84%)
Comorbidity 68 (49%) 25 (53%) 43 (44%) 0.437 1.321 0.654–2.667    
vs. no comorbidity 72 (51%) 22 (47%) 50 (56%)
Treatment: ABVD 43 (31%) 16 (34%) 27 (30%) 0.599 1.224 0.576–2.597    
vs. other 95 (69%) 31 (66%) 64 (70%)
Irradiation 103 (74%) 35 (74%) 68 (73%) 0.864 1.072 0.482–2.387    
vs. no irradiation 37 (26%) 12 (26%) 25 (27%)
Treatment response: PR 72 (51%) 4 (9%) 5 (5%) 0.484 1.637 0.418–6.409    
vs. SD 68 (49%) 43 (81%) 88 (95%)
Treatment related side effect: yes 72 (51%) 36 (77%) 36 (39%) <0.001 5.182 2.343–11.460 <0.001 5.254 2.196–12.524
vs. no 68 (49%) 11 (23%) 57 (61%)
Relapse 21 (15%) 7 (15%) 14 (15%) 0.980 0.983 0.369–2.641    
vs. no relapse 119 (85%) 40 (85%) 79 (85%)